Maxwellia

Macclesfield, United Kingdom · Founded 2013 · Privately Held (backing)

Developer of a consumer healthcare platform designed to increase access to medicines by transforming prescription-only drugs into over-the-counter brands. Maxwellia is based in Macclesfield, United Kingdom and was founded in 2013. Its last reported valuation was $29.9 million in Jun 2025. It has raised $27.5 million.

Last reported valuation
$29.9M
Oct 2026
Priced at
—
Total raised
$27.5M
Last round
—

Who backs Maxwellia?

13 investors
InvestorType
Innovate UKOther
British Business BankOther
Praetura VenturesVenture capital
Alderley Park—
Catapult Ventures—
Channel 4 Ventures—
Future Fund (UK)—
Global Prime Partners (Australia)—
HNW (Investor)—
John Gunn—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Maxwellia investors

13 investors are on record for Maxwellia, including Innovate UK, British Business Bank, Praetura Ventures and Alderley Park.

Free account
More of Maxwellia with a free account
  • ·The complete investor list: 13 names
  • ·Watch Maxwellia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Maxwellia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View